{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T03:38:36Z","timestamp":1768966716204,"version":"3.49.0"},"reference-count":14,"publisher":"Japanese Society of Internal Medicine","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,11,15]]},"DOI":"10.2169\/internalmedicine.9239-21","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T22:11:07Z","timestamp":1648851067000},"page":"3409-3414","source":"Crossref","is-referenced-by-count":5,"title":["Fulminant Respiratory Failure Caused by Anti-asparaginyl tRNA Synthetase (Anti-KS) Antibody Syndrome-related Interstitial Lung Disease"],"prefix":"10.2169","volume":"61","author":[{"given":"Naohiro","family":"Oda","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Fukuyama City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Department of Allergy and Respiratory Medicine, Okayama University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Aokage","sequence":"additional","affiliation":[{"name":"Advanced Emergency and Critical Care Medical Center, Okayama University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Senoo","sequence":"additional","affiliation":[{"name":"Department of Allergy and Respiratory Medicine, Okayama University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Nagashima","sequence":"additional","affiliation":[{"name":"Emergency Medical Center, Fukuyama City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reo","family":"Mitani","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Fukuyama City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Takata","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Fukuyama City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuaki","family":"Miyahara","sequence":"additional","affiliation":[{"name":"Department of Allergy and Respiratory Medicine, Okayama University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Hamaguchi Y, Fujimoto M, Matsushita T, et al. Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome. PLoS One 8: e60442, 2013.","DOI":"10.1371\/journal.pone.0060442"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Shi J, Li S, Yang H, et al. Clinical profiles and prognosis of patients with distinct antisynthetase autoantibodies. J Rheumatol 44: 1051-1057, 2017.","DOI":"10.3899\/jrheum.161480"},{"key":"3","unstructured":"3. Hirakata M, Suwa A, Nagai S, et al. Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease. J Immunol 162: 2315-2320, 1999."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hirakata M, Suwa A, Takada T, et al. Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase. Arthritis Rheum 56: 1295-1303, 2007.","DOI":"10.1002\/art.22506"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Schneider F, Aggarwal R, Bi D, Gibson K, Oddis C, Yousem SA. The pulmonary histopathology of anti-KS transfer RNA synthetase syndrome. Arch Pathol Lab Med 139: 122-125, 2015.","DOI":"10.5858\/arpa.2013-0667-OA"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ge Y, Li S, Li S, He L, Lu X, Wang G. Interstitial lung disease is a major characteristic of anti-KS associated ant-synthetase syndrome. Ther Adv Chronic Dis 11: 2040622320968417, 2020.","DOI":"10.1177\/2040622320968417"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Aiko N, Yamakawa H, Iwasawa T, et al. Clinical, radiological, and pathological features of anti-asparaginyl tRNA synthetase antibody-related interstitial lung disease. Respir Investig 58: 196-203, 2020.","DOI":"10.1016\/j.resinv.2019.12.003"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Fujibayashi T, Sugai S, Miyasaka N, Hayashi Y, Tsubota K. Revised Japanese criteria for Sj\u00f6gren's syndrome (1999): availability and validity. Mod Rheumatol 14: 425-434, 2004.","DOI":"10.1007\/s10165-004-0338-x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ito I, Nagai S, Kitaichi M, et al. Pulmonary manifestations of primary Sj\u00f6gren's syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med 171: 632-638, 2005.","DOI":"10.1164\/rccm.200403-417OC"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Yamakawa H, Hagiwara E, Kitamura H, et al. Predictive factors for the long-term deterioration of pulmonary function in interstitial lung disease associated with anti-aminoacyl-tRNA synthetase antibodies. Respiration 96: 210-221, 2018.","DOI":"10.1159\/000488358"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Takei R, Yamano Y, Kataoka K, et al. Predictive factors for the recurrence of anti-aminoacyl-tRNA synthetase antibody-associated interstitial lung disease. Respir Investig 58: 83-90, 2020.","DOI":"10.1016\/j.resinv.2019.10.004"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Debray MP, Borie R, Revel MP, et al. Interstitial lung disease in anti-synthetase syndrome: initial and follow-up CT findings. Eur J Radiol 84: 516-523, 2015.","DOI":"10.1016\/j.ejrad.2014.11.026"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Trudzinski FC, Kaestner F, Sch\u00e4fers HJ, et al. Outcome of patients with interstitial lung disease treated with extracorporeal membrane oxygenation for acute respiratory failure. Am J Respir Crit Care Med 193: 527-533, 2016.","DOI":"10.1164\/rccm.201508-1701OC"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Gon\u00e7alves-Venade G, Lacerda-Pr\u00edncipe N, Roncon-Albuquerque R Jr, Paiva JA. Extracorporeal membrane oxygenation for refractory severe respiratory failure in acute interstitial pneumonia. Artif Organs 42: 569-574, 2018.","DOI":"10.1111\/aor.13075"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/22\/61_9239-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T03:21:02Z","timestamp":1668828062000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/22\/61_9239-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,15]]},"references-count":14,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9239-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,15]]},"article-number":"9239-21"}}